09199982 is referenced by 3 patents and cites 280 patents.

The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.

Title
Heterocyclylamines as PI3K inhibitors
Application Number
13/601349
Publication Number
9199982 (B2)
Application Date
August 31, 2012
Publication Date
December 1, 2015
Inventor
Song Mei
Wilmington
DE, US
Brent Douty
Fallowfield
PA, US
Eddy W Yue
Landenberg
PA, US
Andrew P Combs
Kennett Square
PA, US
Yun Long Li
Chadds Ford
PA, US
Agent
Fish & Richardson P C
Assignee
Incyte Corporation
DE, US
Incyte Holdings Corporation
DE, US
IPC
C07D 487/04
C07D 471/04
View Original Source